Webinar: Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease

Learn about new recommendations for the use of statin therapy in people with HIV, its potential to reduce cardiovascular disease and the implications for clinical care in this one-hour webinar. Continuing education credit will be available.

Target Audience

  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Pharmacists
  • Nurses

Learning Objectives

At the conclusion of this session, participants will be able to:

  • Describe the risk for cardiovascular disease among people with HIV
  • Evaluate the use of statin therapy in people with HIV
  • Discuss the benefits and risk of statin therapy with people with HIV
  • Describe how to implement the statin therapy recommendations with the healthcare team
Course summary
Available credit: 
  • 1.00 ABIM MOC II
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit(s)™
Course opens: 
04/25/2024
Course expires: 
04/25/2025

Moderators:

custom photo of speakerAllison Agwu, MD, ScM, FIDSA
HIVMA Chair, Professor of Pediatric and Adult Infectious Diseases
Johns Hopkins University School of Medicine
Disclosures: Gilead Sciences, ViiV Healthcare, Merck:  Scientific Advisory Board, Advisory/Consultant Role (Inactive)

 

 

custom photo of speaker

William R. Short, MD, MPH, FIDSA
Chair, AAHIVM, Associate Professor of Medicine
UPenn Perelman School of Medicine
Disclosures: Gilead Sciences, ViiV Healthcare:  Advisory/Consultant Role

 

 

New Statin Therapy Recommendations for People with HIV

custom photo of speakerGrace McComsey, MD
Vice President of Research and Associate Chief Scientific Officer
University Hospitals (UH) Health System in Cleveland
Disclosures: GSK/ViiV Healthcare, Gilead Sciences, Merck:  Advisory/Consultant (Inactive)​

 

 

Panel Discussion/Q&A:

custom photo of speakerJeff Berry
Executive Director
The Reunion Project
Disclosures: Gilead Sciences, ViiV Healthcare: Advisory/Consultant Role

 

 

custom photo of speakerGrace McComsey, MD
Vice President of Research and Associate Chief Scientific Officer
University Hospitals (UH) Health System in Cleveland
Gilead Sciences, ViiV Healthcare: Advisory/Consultant Role

 

 

custom photo of speakerNeha Pandit, PharmD
Professor
University of Maryland School of Pharmacy
Disclosures: Nothing to disclose. 

 

 

custom photo of speakerRoquell Elvinese Wyche, MD
Cardiovascular Disease Specialist
MedStar Health
Disclosures: Nothing to disclose. 

 

Staff/Planning Committee Members:

  • Allison Agwu, MD, ScM, FIDSA, HIVMA Chair, Professor of Pediatric and Adult Infectious Diseases at the Johns Hopkins University School of 
    Medicine
    Disclosures: Gilead Sciences, ViiV Healthcare, Merck: Scientific Advisory Board, Advisory/Consultant Role (Inactive)
  • William Short, MD, MPH, Chair, AAHIVM, Associate Professor of Medicine, UPenn Perelman School of Medicine, Philadelphia, PA
    Disclosures: Gilead Sciences, ViiV Healthcare: Advisory/Consultant Role
  • Andrea Weddle, HIVMA Executive Director
    Disclosures: Nothing to disclose. 
  • Scott Brawley, MSW, Development Director, Policy and Programs
    Disclosures: Nothing to disclose. 
  • Bruce Packett II, AAHIVM Executive Director
    Disclosures: Nothing to disclose. 
  • Deja Robinson, Education Program Manager
    Disclosures: Nothing to disclose. 
  • Kristin Unwin, Program & Governance Specialist
    Disclosures: Nothing to disclose. 

Accreditation Statement
In support of improving patient care, IDSA is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement
IDSA designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

CPE Accreditation Statement for Pharmacists

IDSA is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. ACPE Universal Activity Number (JA0007082-0000-24-001-H01-P) has been assigned to this knowledge-based activity. This activity is acceptable for a maximum of 1 on-demand CPE contact hours (1 CEU) in states that recognize ACPE providers. 

Upon completion of this ACPE-approved activity, participants will receive 1 credit that will be automatically uploaded to their NABP e-Profile section of the CPE Monitor. It is the participant's responsibility to upload the correct NABP number to their profile.

Physician participation information will be shared with ABIM through ACCME PARS.

CE Subcommittee reviewed all financial disclosures. All relevant financial relationships have been mitigated.

Available Credit

  • 1.00 ABIM MOC II
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit(s)™
Please login or register to take this course.